Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2018, provides an overview of the Dilated Cardiomyopathy (Cardiovascular) pipeline landscape.
Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. Symptoms include Fatigue and weakness, Shortness of breath (dyspnea), lightheadedness, dizziness or fainting, persistent cough or wheezing, lack of appetite, sudden weight gain from fluid retention and swelling (edema) in legs, ankles and feet. Risk factors include family history, alcoholism, hypertension, cocaine abuse and metabolic disorders, such as thyroid disease or diabetes.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Dilated Cardiomyopathy (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 3, 3, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Dilated Cardiomyopathy (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Dilated Cardiomyopathy (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Dilated Cardiomyopathy (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dilated Cardiomyopathy (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dilated Cardiomyopathy (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dilated Cardiomyopathy (Cardiovascular)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dilated Cardiomyopathy (Cardiovascular).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dilated Cardiomyopathy (Cardiovascular) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Dilated Cardiomyopathy - Pipeline Review, H1 2018
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dilated Cardiomyopathy - Overview
Dilated Cardiomyopathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Dilated Cardiomyopathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Dilated Cardiomyopathy - Companies Involved in Therapeutics Development
Array BioPharma Inc
C&C BioPharma LLC
Capricor Therapeutics Inc
Hemostemix Inc
Kasiak Research Pvt Ltd
MyoKardia Inc
Sanofi
Vericel Corp
Dilated Cardiomyopathy - Drug Profiles
ACP-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARRY-797 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BC-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CAP-1002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DCM-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Dilated Cardiomyopathy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ixmyelocel-T - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LUS-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Refacell-DCM - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SAR-440181 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit MEF2 for Cardiovascular Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YS-1402 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Dilated Cardiomyopathy - Dormant Projects
Dilated Cardiomyopathy - Product Development Milestones
Featured News & Press Releases
Nov 02, 2017: MyoKardia Provides Update on MYK-491
Oct 05, 2017: Vericel Provides Update on ixmyelocel-T at 2017 Cell & Gene Meeting on the Mesa
Sep 27, 2017: MyoKardia Provides Update on MYK-491 Clinical Progress
May 10, 2017: Vericel Receives FDA Regenerative Medicine Advanced Therapy Designation for Ixmyelocel-T for the Treatment of Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy
Feb 02, 2017: First Subjects Dosed in MyoKardia Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491
Dec 02, 2016: MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491
Aug 30, 2016: Array Presents Data from Cardiovascular Trial with ARRY-797 at the European Society of Cardiology Congress
Apr 04, 2016: Results from Vericel Positive Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T Presented at ACC and Published in The Lancet
Mar 28, 2016: Vericel Announces Publication of Clinical Trial Rationale and Study Design for the Phase 2b ixCELL-DCM Trial of Ixmyelocel-T in Patients with Heart Failure Due to Ischemic Dilated Cardiomyopathy
Mar 10, 2016: Vericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T in Patients With Heart Failure Due to Ischemic Dilated Cardiomyopathy
Jan 29, 2015: Vericel Completes Patient Enrollment in Phase 2b ixCELL-DCM Clinical Study of Ixmyelocel-T
Dec 19, 2013: Aastrom Biosciences Granted Composition-of-Matter Patent for Ixmyelocel-T in Australia
Dec 17, 2013: Capricor Therapeutics Cleared to Begin Phase II Portion of ALLSTAR Clinical Trial with CAP-1002 in Patients Following Heart Attack
Apr 19, 2013: Aastrom Biosciences Announces First Patients Treated In IxCELL-DCM Clinical Study Of Ixmyelocel-T
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Dilated Cardiomyopathy, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Dilated Cardiomyopathy - Pipeline by Array BioPharma Inc, H1 2018
Dilated Cardiomyopathy - Pipeline by C&C BioPharma LLC, H1 2018
Dilated Cardiomyopathy - Pipeline by Capricor Therapeutics Inc, H1 2018
Dilated Cardiomyopathy - Pipeline by Hemostemix Inc, H1 2018
Dilated Cardiomyopathy - Pipeline by Kasiak Research Pvt Ltd, H1 2018
Dilated Cardiomyopathy - Pipeline by MyoKardia Inc, H1 2018
Dilated Cardiomyopathy - Pipeline by Sanofi, H1 2018
Dilated Cardiomyopathy - Pipeline by Vericel Corp, H1 2018
Dilated Cardiomyopathy - Dormant Projects, H1 2018
List of Figures
Number of Products under Development for Dilated Cardiomyopathy, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products by Targets, H1 2018
Number of Products by Stage and Targets, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
Global Thoracic Surgery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 118
Market Overview of Global Thoracic Surgery market:
According to our latest research, the global Thoracic Surgery market looks promising in the next 5 years. As of 2022, the global Thoracic Surgery market was estimated at USD 3777.06 million, and it's anticipated to reach USD 4689.46 million in 2028, with a CAGR of 3.67% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Thoracic Su......
Global Angina Pectoris Treatment Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 125
Report Overview:
The Global Angina Pectoris Treatment Market Size was estimated at USD 8809.40 million in 2022 and is projected to reach USD 9981.15 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.
This report provides a deep insight into the global Angina Pectoris Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
Global Dilated Cardiomyopathy Therapeutics Market Status and Outlook 2023-2028
Published: 22-Nov-2023 Price: US 3160 Onwards Pages: 100
Dilated cardiomyopathy is currently defined by the presence of left ventricular (LV) or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions (hypertension, valve disease) or coronary artery disease sufficient to cause global systolic impairment.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for ea......
Global Transcatheter Mitral Valve Replacement Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Sep-2023 Price: US 3380 Onwards Pages: 112
Market Overview of Global Transcatheter Mitral Valve Replacement market:
According to our latest research, the global Transcatheter Mitral Valve Replacement market looks promising in the next 5 years. As of 2022, the global Transcatheter Mitral Valve Replacement market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a dee......
Global Thoracic Surgery Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 92
Thoracic surgery is a procedure to treat medical conditions involving heart and lungs. It includes therapies such as redo heart surgery, aortic dissection for aortic surgery, minimally invasive mitral valve repair and replacement, and endovascular repair of thoracic aortic aneurysms.
Market Analysis and Insights: Global Thoracic Surgery Market
The global Thoracic Surgery market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth......
Global Angina Pectoris Treatment Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 29-Jun-2023 Price: US 3260 Onwards Pages: 120
The Angina Pectoris Treatment market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Angina Pectoris Treatment industry, and breaks down according to the type, application, and consumption area of Angina Pectoris Treatment. The report also introduces players in the industry from the perspective of the industry chain and marketing ......
Global Transcatheter Mitral Valve Replacement Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 15-Jun-2023 Price: US 3260 Onwards Pages: 109
The Transcatheter Mitral Valve Replacement market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Transcatheter Mitral Valve Replacement industry, and breaks down according to the type, application, and consumption area of Transcatheter Mitral Valve Replacement. The report also introduces players in the industry from the perspecti......
Global Angina Pectoris Treatment Market Size, Share and Industry Analysis by Regions, Countries, Types, and Applications, Forecast to 2028
Published: 19-May-2023 Price: US 3480 Onwards Pages: 105
The global Angina Pectoris Treatment market size was valued at USD XX Million in 2022 and will reach USD XX Million in 2028, with a CAGR of XX% during 2022-2028.
The Angina Pectoris Treatment market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types......
Global Thoracic Surgery Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 16-May-2023 Price: US 3260 Onwards Pages: 100
The Thoracic Surgery market revenue was 3777.06 Million USD in 2022, and will reach 4689.46 Million USD in 2028, with a CAGR of 3.67% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Thoracic Surgery industry, and breaks down according to the type, application, and consumption area of Thoracic Surgery. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and descr......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
